XSPRAY PHARMA Trademark

Trademark Overview

On Thursday, December 16, 2021, a trademark application was filed for XSPRAY PHARMA with the United States Patent and Trademark Office. The USPTO has given the XSPRAY PHARMA trademark a serial number of 97175755. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, July 30, 2024. This trademark is owned by Xspray Pharma AB. The XSPRAY PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, protein kinase inhibitors
xspray pharma

General Information

Serial Number97175755
Word MarkXSPRAY PHARMA
Filing DateThursday, December 16, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Goods and ServicesPharmaceuticals, namely, protein kinase inhibitors
NOT AVAILABLE"PHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXspray Pharma AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSolna SE-16967
SE
Party NameXspray Pharma AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSolna SE-16967
SE

Trademark Events

Event DateEvent Description
Monday, May 9, 2022ASSIGNED TO EXAMINER
Tuesday, May 10, 2022EXAMINERS AMENDMENT E-MAILED
Monday, December 20, 2021NEW APPLICATION ENTERED
Tuesday, December 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 10, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 10, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 10, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, May 17, 2022ASSIGNED TO LIE
Tuesday, May 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, February 6, 2023SOU EXTENSION 1 FILED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, February 6, 2023SOU EXTENSION 1 GRANTED
Tuesday, July 25, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 25, 2023SOU EXTENSION 2 FILED
Tuesday, July 25, 2023SOU EXTENSION 2 GRANTED
Thursday, February 8, 2024SOU EXTENSION 3 GRANTED
Tuesday, July 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2024SOU EXTENSION 4 GRANTED
Tuesday, July 30, 2024SOU EXTENSION 4 FILED
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 8, 2024SOU EXTENSION 3 FILED

Related Keywords

pharma xspray inhibitors kinase protein namely pharmaceuticals